Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis
dc.contributor.author | Koca, Süleyman Serdar | |
dc.contributor.author | Öz, Burak | |
dc.contributor.author | Karataş, Ahmet | |
dc.contributor.author | Can, Gercek | |
dc.contributor.author | Şenel, Soner | |
dc.contributor.author | Yazıcı, Ayten | |
dc.contributor.author | İnanç, Nevsun | |
dc.contributor.author | Cefle, Ayşe | |
dc.contributor.author | Ertürk, Zeynep | |
dc.contributor.author | Akar, Servet | |
dc.contributor.author | Göker, Berna | |
dc.contributor.author | Birlik, Merih | |
dc.contributor.author | Önen, Fatoş | |
dc.contributor.buuauthor | Dalkılıç, Ediz | |
dc.contributor.buuauthor | Pehlivan, Yavuz | |
dc.contributor.buuauthor | Yağız, Burcu | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı/Romatoloji Bilim Dalı. | tr_TR |
dc.contributor.researcherid | AAG-8227-2021 | tr_TR |
dc.date.accessioned | 2023-11-10T07:06:17Z | |
dc.date.available | 2023-11-10T07:06:17Z | |
dc.date.issued | 2018-06 | |
dc.description | Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur. | tr_TR |
dc.description.sponsorship | European League Against Rheumatism | en_US |
dc.identifier.citation | Koca, S. S. vd. (2018). ''Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 597-597. | en_US |
dc.identifier.endpage | 597 | tr_TR |
dc.identifier.issn | 0003-4967 | |
dc.identifier.issn | 1468-2060 | |
dc.identifier.issue | Supplement 2 | en_US |
dc.identifier.startpage | 597 | tr_TR |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2018-eular.5819 | |
dc.identifier.uri | https://ard.bmj.com/content/77/Suppl_2/597.1 | |
dc.identifier.uri | http://hdl.handle.net/11452/34832 | |
dc.identifier.volume | 77 | tr_TR |
dc.identifier.wos | 000444351001568 | |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | BMJ | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.journal | Annals of the Rheumatic Diseases | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Rheumatology | en_US |
dc.subject.wos | Rheumatology | en_US |
dc.title | Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | en_US |